Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Scientists unpick actions of faulty gene behind red meat bowel cancer risk

13 August 2012

By Cait McDonagh

Appeared in BioNews 668

A faulty gene linked to bowel cancer interacts with dietary iron to significantly increase the risk of developing the disease, research on mice suggests.

Professor Owen Sansom, deputy director of the Cancer Research UK Institute for Cancer Research in Glasgow, who led the study, said that the gene in question, called APC, 'is faulty in around eight out of ten bowel cancers but until now we haven't known how this causes the disease'.

Bowel cancer is the third most common cancer in the UK, with 41,000 cases diagnosed each year. Around 16,000 of people die from the disease annually.

The scientists tested mice with and without the faulty gene and fed one group a diet high in iron and another no iron. They found that the iron reacted with the non-working gene to drastically increase the likelihood of developing bowel cancer. The risk was two to three times higher than those mice that had a working APC gene.

Writing in the journal Cell Reports, the researchers say that the faulty APC gene allows iron to build up in the cells lining the gut. This activates a key cancer signalling pathway called wnt, causing cells to grow out of control.

The study may explain why diets high in red meat, which contains a lot of iron, are associated with bowel cancer. But Professor Sansom commented that the study 'shows that even very high levels of iron in the diet don't cause cancer by itself, but rely on the APC gene'. The mice with the faulty APC gene that were fed with a low iron diet did not develop the disease as the faulty cells were killed.

Co-author Dr Chris Tselepis, a Cancer Research UK scientist at the University of Birmingham, said: 'Our results also suggest that iron could be raising the risk of bowel cancer by increasing the number of cells in the bowel with APC faults. The more of these cells in the bowel, the greater the chance that one of these will become a starting point for cancer'.

He added that the team was 'planning to develop treatments that reduce the amount of iron in the bowel and so could lower the risk of developing bowel cancer'.

SOURCES & REFERENCES
Iron 'may raise bowel cancer risk'
Press Association | 09 August 2012
 
Cell Reports | 09 August 2012
 
Mail Online | 09 August 2012
 
Cancer Research UK (press release) | 09 August 2012
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

25 January 2016 - by Hannah Somers 
Scientists in the USA have identified a biomarker that could predict which patients with colon cancer might benefit from chemotherapy to prevent recurrences of the disease after surgical treatment....
23 March 2015 - by Rhys Baker 
Whether or not aspirin reduces a person's risk of bowel cancer could all be down to their genetic make-up, according to a US study...
06 May 2014 - by James Brooks 
A genetic variant carried by one in three people raises the risk of bowel cancer for people who eat a lot of processed meat, a study has found...
19 August 2013 - by Dr Lux Fatimathas 
Claims for the health benefits of the typically Mediterranean diet high in olive oil, fish, and complex carbohydrates are common, if hard to substantiate...
04 March 2013 - by Reuben Harwood 
Losing genes that help stabilise a cells DNA may explain why some cancers are resistant to treatment, say scientists...

23 July 2012 - by Holly Rogers 
A genetic variation could explain why a previously promising class of drugs do not work as multiple sclerosis treatments despite being used successfully in other autoimmune diseases...
19 December 2011 - by Sarah Pritchard 
A gene known as deleted colorectal carcinoma (DCC) could safeguard against the development of the colorectal cancer by inducing a process called apoptosis, or cell death...
31 October 2011 - by Suzanne Elvidge 
Taking a daily aspirin has been recommended for people with a high risk of an inherited form of bowel cancer. Results published in The Lancet suggested the risk for those with Lynch syndrome could be cut by 63 percent...
22 November 2010 - by Sarah Pritchard 
UK researchers have identified a type of genetic variation which allows bowel cancer patients to live on average three months longer than those without the variant....
07 June 2010 - by Dr Sophie Pryor 
US scientists have identified a region of DNA, which may contain a novel gene responsible for the progression and spread of colorectal (bowel) cancer....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation